Diagnostic value of serum brain-derived neurotrophic factor (BDNF), neuronspecific enolase (NSE), glial fibrillary acidic protein (GFAP), plasma viscosity (PV) as well as fibrinogen (FIB) in acute cerebral infarction patients
Diagnostic value of serum brain-derived neurotrophic factor (BDNF), neuronspecific enolase (NSE), glial fibrillary acidic protein (GFAP), plasma viscosity (PV) as well as fibrinogen (FIB)
Abstract
Objective: To explore the Diagnostic value of serum brain-derived neurotrophic factor (BDNF), neuronspecific enolase (NSE), glial fibrillary acidic protein (GFAP), plasma viscosity (PV) as well as fibrinogen (FIB) in patients receiving butylphthalide and sodium chloride injection in combination with atorvastatin calcium in acute cerebral infarction patients.
Methods: Eighty ACI patients accepted therapy in our hospital from January 2022 to January 2024 were included to be study objects, followed by dividing into control group (CG) and study group (SG). The CG was given atorvastatin calcium tablets. On the basis of the CG, the SG accepted butylphthalide and sodium chloride injection. The clinical efficacy, neurological impairment, activity of daily living ability, hemorheological indicators, neurobiochemical indicators, and occurrence of adverse reactions in 2 groups were compared.
Results: Relative to the CG, the total effective clinical effect rate in the SG presented elevation (P<0.05). After therapy, the NIHSS score in the SG presented reduction relative to the CG, BI score in the SG presented higher relative to the CG (P<0.05), the whole blood high shear viscosity, whole blood low shear viscosity, PV, HCT as well as FIB levels in the SG presented reduction relative to the CG (P<0.05), the improvements of BDNF, NSE and GFAP levels in the SG were superior to the CG (P<0.05), and the occurrence of adverse reactions between 2 groups was no significant (P>0.05).
Conclusion: Butylphthalide sodium chloride injection in combination with atorvastatin calcium tablets can improve the total therapeutic response rate, improve neurological impairment, promote patients’ daily life ability, improve cerebral hemodynamics and neurobiochemical indexes in the therapy of ACI patients, which is worthy for clinical promotion.
References
2. Li, C., et al., Severe Thrombocytopenia with Acute Cerebral Infarction: A Case Report and Literature Review. Niger J Clin Pract, 2023. 26(7): p. 1040-1044.
3. Edwards, M.D. and T.A.T. Hughes, Managing blood pressure in acute cerebral infarction. J Neurol, 2021. 268(6): p. 2294-2296.
4. NanZhu, Y., et al., Salvianolate injection in the treatment of acute cerebral infarction: A systematic review and a meta-analysis. Medicine (Baltimore), 2018. 97(47): p. e12374.
5. Ji, J., et al., Efficacy of Fuyuan Xingshen Decoction Combined with Butylphthalide Sodium Chloride Injection in the Treatment of Acute Cerebral Infarction and Its Effect on Hemodynamics. Evid Based Complement Alternat Med, 2022. 2022: p. 2402040.
6. Zhang, H., et al., Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study. Neural Regen Res, 2020. 15(7): p. 1266-1273.
7. Yang, D., et al., Clinical Efficacy and Short-Term Prognosis of Butylphthalide and Sodium Chloride Injection Compared to Edaravone in the Treatment of Patients with Acute Stroke. Altern Ther Health Med, 2023. 29(7): p. 370-375.
8. Li, R., et al., Atorvastatin calcium tablets on inflammatory factors, hemorheology and renal function damage indexes in patients with diabetic nephropathy. Pak J Med Sci, 2021. 37(5): p. 1392-1396.
9. Guan, Y., et al., Separability of Acute Cerebral Infarction Lesions in CT Based Radiomics: Toward Artificial Intelligence-Assisted Diagnosis. Biomed Res Int, 2020. 2020: p. 8864756.
10. Katsura, K., et al., Brain protection therapy in acute cerebral infarction. J Nippon Med Sch, 2012. 79(2): p. 104-10.
11. Chen, X., et al., Research of Sleep Disorders in Patients with Acute Cerebral Infarction. J Stroke Cerebrovasc Dis, 2015. 24(11): p. 2508-13.
12. Yu, L., et al., Atorvastatin inhibits neuronal apoptosis via activating cAMP/PKA/p-CREB/BDNF pathway in hypoxic-ischemic neonatal rats. Faseb j, 2022. 36(4): p. e22263.
13. Jiang, R., et al., Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial. JAMA Neurol, 2018. 75(11): p. 1338-1346.
14. Chen, J., et al., Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults. Aging (Albany NY), 2020. 12(3): p. 2939-2951.
15. Niu, H., et al., The impact of butylphthalide on the hypothalamus-pituitary-adrenal axis of patients suffering from cerebral infarction in the basal ganglia. Electron Physician, 2016. 8(1): p. 1759-63.
16. Cui, J. and H. Jia, Xingnao Kaiqiao Acupuncture Combined with Butylphthalide Sodium Chloride Injection in the Treatment of Acute Cerebral Infarction and Its Effect on the Levels of Serum Malondialdehyde, Superoxide Dismutase, and Glutathione Peroxidase. Evid Based Complement Alternat Med, 2022. 2022: p. 5990203.
17. Wang, A., et al., Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol, 2023. 80(8): p. 851-859.
18. Wang, S., et al., Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke. CNS Neurol Disord Drug Targets, 2018. 17(5): p. 338-347.
19. Xie, K., S. Zhao, and X. Li, Efficacy and Mechanism of Butylphthalide Combined with Atorvastatin Calcium Tablets in the Diagnosis of Cerebral Infarction Using Iodol/Fe₃O₄ Nanometric Contrast Agent. J Nanosci Nanotechnol, 2020. 20(12): p. 7356-7361.
20. Palasz, E., et al., BDNF as a Promising Therapeutic Agent in Parkinson's Disease. Int J Mol Sci, 2020. 21(3).
21. Liu, K., et al., Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway. Front Pharmacol, 2022. 13: p. 832611.
22. Arnason, S., et al., Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome. Eur J Clin Microbiol Infect Dis, 2022. 41(7): p. 1051-1057.
23. Middeldorp, J. and E.M. Hol, GFAP in health and disease. Prog Neurobiol, 2011. 93(3): p. 421-43.
24. Hu, C., et al., [Expression levels of ubiquitin C-terminal hydrolase-L1 and serum glial fibrillary acidic protein and its clinical significance in patients with acute cerebral infarction]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2017. 42(3): p. 284-290.
25. Guo, Y., et al., Cerebral hemodynamic changes assessment by transcranial doppler ultrasound in patients with acute cerebral infarction before and after treatment with butylphthalide. Pak J Pharm Sci, 2022. 35(2(Special)): p. 613-618.
26. Peters, N., et al., Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL. J Neurol Sci, 2007. 260(1-2): p. 100-5.
27. Li, K., et al., Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke. J Healthc Eng, 2022. 2022: p. 1509407.
Copyright (c) 2025 Fei Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.